FINDRISC (Finnish Diabetes Risk Score)
FINDRISC estimates the 10‑year risk of developing type 2 diabetes using simple non‑laboratory factors.
Indications for Use
Used for adults undergoing noncardiac surgery to estimate 30‑day MACE risk, especially when determining whether risk is <1% vs ≥1% to guide further testing or management (AHA/ACC 2024 1 [Level I evidence]). Applies best to elective/urgent surgery; poorly validated in vascular surgery 2 [Level II evidence].
Used to screen asymptomatic adults in primary care to estimate 10‑year type 2 diabetes risk and guide lifestyle intervention; widely used epidemiologic tool with moderate discrimination 3 [Level II evidence].
Insights & Cautions
Identifies high‑risk individuals reasonably well but has moderate discrimination (AUC ~0.69–0.76) and high false‑positive rates at common cutoffs 1 [Level I evidence]. Performance varies by population and often requires recalibration; accuracy is lower in older adults 2 [Level II evidence]. Newer multivariable or laboratory‑based models consistently outperform it (AUC 0.66 vs 0.87) 3 [Level II evidence].